The second session of the International Symposium on Evidence-based Chinese Medicine was held, the experts suggested

Carrying out traditional Chinese medicine anti - infection high quality clinical research

Time: 2017-04-24 Source: Chinese Medicine News Author: Zhao Weiting

      Current infectious disease prevention and treatment is facing major challenges such as the lag of the vaccine, the variability of the virus, and the resistance of the chemical drug. April 21 to 23, the second session of the International Forum on Evidence-Based Medicine, from China, Britain, Italy, South Korea and other countries of the epidemiology, Chinese medicine and evidence-based medicine experts gathered in Hangzhou, Zhejiang, to discuss the prevention and treatment of Chinese medicine infection The advantages and evidence of the disease.

      To carry out high-quality clinical research, for the prevention and treatment of infectious diseases of Chinese medicine to provide clinical evidence is the consensus of experts. The database of clinical evidence for Chinese medicine is started in the same period. The database contains a validation database, an acupuncture and moxibustion clinical database and a safety database.

      Chinese Academy of Traditional Chinese Medicine, President of Tianjin University of Traditional Chinese Medicine Zhang Boli academician that the prevention and treatment of infectious diseases in Chinese medicine has four major advantages, including the prevention of the body's ability to prevent the role of the pathogen to reduce the role of microbial treatment to reduce the damage to the repair of toxins , To reduce the amount of chemical and adverse effects of synergies, worthy of systematic in-depth study to provide high-quality evidence, and evidence-based medicine to evaluate the evidence.

      "World Health Organization Director-General Margaret Chan talked about the grim reality of global disease prevention and control, pointed out that only rely on Western medicine uncertain, new drugs can not afford, why not from the national medicine in the excavation of effective, safe supplement and alternative medicine? Sichuan University, West China Hospital, director of evidence-based medicine research center, WHO basic drug directory review expert group and policy advisory expert group expert Li Youping suggested that anti-infective proprietary Chinese medicine classification system should be similar with similar Western medicine docking, based on high quality basic research and clinical research results, Research and development of innovative drugs and guidelines, modify the instructions, and timely updates.

      The forum was sponsored by the Chinese Society of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Chinese Academy of Traditional Chinese Medicine, Italian National Institutes of Health, China Evidence-Based Medicine Center, Clinical Pharmacology Branch of the Chinese Medicine Association, Internal Medicine Branch of the Chinese Medicine Association, Tianjin Institute of Integrative Medicine Medical professional committee, Tianjin University of Traditional Chinese Medicine Evidence-based medicine center, Chinese medicine injection production and research cooperation organization contractors. Infectious disease diagnosis and treatment of national key laboratories director Li Lanjuan academician to participate in the forum.